Absence of hemolytic disease of fetus and newborn despite maternal high-titer IgG anti-Ku

1.Westhoff CM, Reid ME. Review: the Kell, Duffy, and Kidd blood group systems. Immunohematology 2004;20:37–49.10.21307/immunohematology-2019-420Search in Google Scholar

2.Bowman JM, Pollock JM, Manning FA, Harman CR, Menticoglou S. Maternal Kell blood group alloimmunization. Obstet Gynecol 1992;79:239–44.10.1016/0020-7292(92)90957-KSearch in Google Scholar

3.Daniels G. Kell and Kx blood group systems. In: Daniels G. ed. Human blood groups. 2nd ed. Oxford, UK: Blackwell Science Ltd, 2002:304.Search in Google Scholar

4.Lin M, Wang CL, Chen FS, Ho LH. Fatal hemolytic transfusion reaction due to anti-Ku in a K null patient. Immunohematology 2003;19:19–21.10.21307/immunohematology-2019-469Search in Google Scholar

5.Huang HJ, Tagawa H. Hemolytic disease of the newborn due to anti-Ku [in Japanese]. Nippon Sanka Fujinka Gakkai Zasshi 1982;34:119–21.Search in Google Scholar

6.Fourmaintraux A, Vitrac D, Mariette JB, Brunel F. The K₀phenotype and fetal-maternal alloimmunization [in French]. Arch Fr Pediatr 1993;50:779–81.Search in Google Scholar

7.Manoura A, Korakaki E, Hatzidaki E, et al. Use of recombinant erythropoietin for the management of severe hemolytic disease of the newborn of a K₀phenotype mother. Pediatr Hematol Oncol 2007;24:69–73.10.1080/0888001060100145317130116Search in Google Scholar

8.Lydaki E, Nikoloudi I, Kaminopetros P, et al. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku. Transfusion 2005;45:1791–5.10.1111/j.1537-2995.2005.00604.x16271105Search in Google Scholar

9.Corcoran PA, Allen FH Jr, Lewis M, Chown B. A new antibody, anti-Ku (anti-Peltz), in the Kell blood-group system. Transfusion 1961;1:181–3.10.1111/j.1537-2995.1961.tb00036.x13695467Search in Google Scholar

10.Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego, CA: Academic Press, 2004.10.1016/B978-012586585-2/50007-XSearch in Google Scholar

11.Subcommittee on hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114:297–316.10.1542/peds.114.1.29715231951Search in Google Scholar

12.Lee S, Russo DC, Reid ME, Redman CM. Mutations that diminish expression of Kell surface protein and lead to the K_modRBC phenotype. Transfusion 2003;43:1121–5.10.1046/j.1537-2995.2003.00472.x12869119Search in Google Scholar